2024 |
Effectiveness and safety of filgotinib in rheumatoid arthritis: a real-life multicentre experience |
Articolo in rivista |
Vai |
2024 |
The Contribution of Innate Immunity in Large-Vessel Vasculitis: Detangling New Pathomechanisms beyond the Onset of Vascular Inflammation |
Articolo in rivista |
Vai |
2023 |
Characterising oesophageal motility disorders by high-resolution impedance manometry in dermatomyositis patients |
Articolo in rivista |
Vai |
2023 |
Severe case of rhabdomyolysis following jellyfish envenomation in the Mediterranean Sea |
Articolo in rivista |
Vai |
2023 |
JAK/STAT inhibition modifies the ILC1 immune response in patients with rheumatoid arthritis |
Articolo in rivista |
Vai |
2023 |
The potential relationship between PU.1 and IL-9 in the development of arthritis |
Lettera |
Vai |
2023 |
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review |
Review essay (rassegna critica) |
Vai |
2023 |
Successful treatment of eosinophilic fasciitis with the anti-IL5 receptor monoclonal antibody benralizumab |
Lettera |
Vai |
2022 |
Microbiome Changes in Connective Tissue Diseases and Vasculitis: Focus on Metabolism and Inflammation |
Articolo in rivista |
Vai |
2022 |
Immunity and Nutrition: The Right Balance in Inflammatory Bowel Disease |
Review essay (rassegna critica) |
Vai |
2020 |
Colchicine as possible treatment of non-cryoglobulinaemic vasculitis in Sjögren's syndrome |
Lettera |
Vai |